Effect of influenza immunization on CYP3A4 activity

Vaccine

Volumn 20, Issue 5-6, 2001, Pages 858-861

  Hayney, Mary S ^a   Hammes, Richard J ^a,b   Fine, Jason P ^c   Bianco, Jesus A ^c  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b University of Wisconsin Health   (United States)

^c UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

CYP3A4; Erythromycin breath test; Influenza vaccine

Indexed keywords

CYTOCHROME P450 3A4; ERYTHROMYCIN; INFLUENZA VACCINE; VIRUS ANTIBODY;

ADULT; ANIMAL CELL; ANTIBODY TITER; BREATH ANALYSIS; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFECT; ENZYME ACTIVITY; FEMALE; HEMAGGLUTINATION INHIBITION TEST; HUMAN; INFLUENZA VACCINATION; MALE; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL;

ADULT; BREATH TESTS; CYTOCHROME P-450 ENZYME SYSTEM; ERYTHROMYCIN; FEMALE; HUMANS; INFLUENZA VACCINES; LIVER; MALE; MIXED FUNCTION OXYGENASES;

EID: 0035852304     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(01)00403-0     Document Type: Conference Paper

References (30)

1. Drug interactions involving immunologic agents. Part I. Vaccine-vaccine, vaccine-immunoglobulin and vaccine-drug interactions
2. Depression of aminopyrine metabolism by influenza vaccination
3. Effect of influenza vaccine on serum concentrations of total and free phenytoin
4. Effect of influenza vaccine on serum anticonvulsant concentrations
5. Effect of influenza vaccination on plasma phenytoin concentrations
6. Increased serum phenytoin concentration following influenza vaccination
7. Decreased elimination of theophylline after influenza vaccination
8. Effects of influenza virus vaccine on hepatic drug metabolism
9. Lack of effect of influenza vaccine on theophylline levels and warfarin anticoagulation in the elderly
10. The effect of whole virus influenza vaccination on theophylline pharmacokinetics
11. Noninvasive tests of CYP3A enzymes
12. Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: Studies with liver microsomes of 30 Japanese and 30 Caucasians
13. Prevention and control of influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
14. P450 3A activity and cyclosporine dosing in kidney and heart transplant recipients
15. Steady-state pharmacokinetics of delavirdine in HIV-positive patients: Effect on erythromycin breath test
16. Predicting drug interactions in vivo from experiments in vitro. Human studies with paclitaxel and ketoconazole
17. Erythromycin breath test as an assay of glucocorticoid-inducible liver cytochromes P-450. Studies in rats and patients
18. Time to earliest peak serum antibody response to influenza vaccine in the elderly
19. Prediction of interpatient and intrapatient variation in OG 37-325 dosing requirements by the erythromycin breath test. A prospective study in renal transplant recipients
20. The erythromycin breath test as a predictor of cyclosporine blood levels
21. Importance of cytochrome P-450IIIA activity in determining dosage and blood levels of FK 506 and cyclosporine in liver transplant recipients
22. The erythromycin breath test selectively measures P450IIIA in patients with severe liver disease
23. Concurrent administration of the erythromycin breath test (EBT) and oral midazolam as in vivo probes for CYP3A activity
24. Phenotyping of drug-metabolizing enzymes in adults: A review of in vivo cytochrome P450 phenotyping probes
25. Failure of erythromycin breath test to correlate with midazolam clearance as a probe of cytochrome P4503A
26. CYP3A4 drug interactions: Correlation of 10 in vitro probe substrates
27. CYP2E1 activity is not altered by influenza vaccination letter
28. Recent advances: The cytochrome P450 enzymes
29. Possible inhibition of hepatic metabolism of quinidine by erythromycin